Sally Wagner Partin
Advertisement
Sally Wagner Partin is a partner at Sidley Austin LLP across life sciences M&A and FDA regulatory practice.
Articles by Sally Wagner Partin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
4
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
5